Cargando…
Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
Autores principales: | Kant, Agnes, van Hunsel, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284101/ https://www.ncbi.nlm.nih.gov/pubmed/35838877 http://dx.doi.org/10.1007/s40264-022-01207-x |
Ejemplares similares
-
Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands
por: Kant, Agnes, et al.
Publicado: (2022) -
Reply to the letter to the editor by Mungmunpuntipantip et al.
por: Longo, M., et al.
Publicado: (2021) -
Response to the Letter to the Editor by Mungmunpuntipantip et al
por: Stamenković, Marija, et al.
Publicado: (2022) -
Answer to Mungmunpuntipantip et al. Joint Bone Spine 2023;90:105518
por: Lombès, Amélie, et al.
Publicado: (2023) -
Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)